Latest News

Amino acid offers potential therapeutic alternative in psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Off-season doesn't allow brain to recover from football hits, study says

  • Rapid whole-brain imaging with single cell resolution

  • Trisomy 21: How an extra little chromosome throws entire genome off balance

  • Anti-seizure drug may reduce alcohol consumption, study shows

  • The ilk of human kindness: Older women with gumption score high on compassion

  • Our relationship with God changes when faced with potential romantic rejection

  • Sporting latest tech toy can make you seem more like a leader

  • Progressive neurodegenerative disorder linked to R-loop formation

  • New pain relief targets discovered by researchers

  • Better way to deal with bad memories suggested

  •